v3.26.3
Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
segment
Sep. 30, 2025
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     2  
Segment Reporting [Line Items]        
Number of reportable segments | segment     2  
Net sales $ 6,520 $ 6,057 $ 19,129 $ 17,945
Reclassification to: cost of sales 2,272 2,205 6,573 6,508
Research, development and engineering expenses 433 410 1,280 1,222
Selling, general and administrative expenses 2,313 2,045 6,823 6,424
Depreciation and amortization 397 402 1,196 1,153
Amortization of intangible assets (175) (189) (530) (543)
Segment operating income 1,034 1,135 3,629 3,085
Goodwill and other impairments (293) (73) (294) (163)
Net earnings 753 859 2,774 2,397
MedSurg and Neurotechnology:        
Segment Reporting [Line Items]        
Net sales 3,664 3,355    
Operating Segments        
Segment Reporting [Line Items]        
Net sales 6,520 6,057 19,129 17,945
Reclassification to: cost of sales 2,185 2,063 6,480 6,057
Research, development and engineering expenses 403 387 1,198 1,142
Selling, general and administrative expenses 1,799 1,678 5,367 5,115
Depreciation and amortization 190 179 568 523
Amortization of intangible assets (175) (189) (530) (543)
Segment operating income 1,943 1,750 5,516 5,108
Operating Segments | MedSurg and Neurotechnology:        
Segment Reporting [Line Items]        
Net sales 3,664 3,355 10,496 9,716
Reclassification to: cost of sales 1,367 1,294 4,001 3,732
Research, development and engineering expenses 242 229 728 666
Selling, general and administrative expenses 944 902 2,817 2,670
Depreciation and amortization 59 56 179 170
Segment operating income 1,052 874 2,771 2,478
Operating Segments | Orthopaedics        
Segment Reporting [Line Items]        
Net sales 2,856 2,702 8,633 8,229
Reclassification to: cost of sales 818 769 2,479 2,325
Research, development and engineering expenses 161 158 470 476
Selling, general and administrative expenses 855 776 2,550 2,445
Depreciation and amortization 131 123 389 353
Segment operating income 891 876 2,745 2,630
Segment Reporting, Reconciling Item, Corporate Nonsegment        
Segment Reporting [Line Items]        
Depreciation and amortization 32 34 98 87
Segment operating income (237) (200) (732) (669)
Segment Reconciling Items        
Segment Reporting [Line Items]        
Amortization of intangible assets (175) (189) (530) (543)
Sale of inventory stepped up to fair value at acquisition 0 (61) 0 (160)
Acquisition and integration-related charges (17) (39) (61) (302)
Structural optimization and other special charges (153) (41) (366) (93)
Goodwill and other impairments (293) (73) (294) (163)
Medical device regulation (6) (11) (16) (30)
Recall-related matters 4 (1) (8) (56)
Regulatory and legal matters (32) 0 (38) (7)
Other Nonoperating Income 0 0 158 0
Net earnings $ 1,034 $ 1,135 $ 3,629 $ 3,085